Atcor Medical Holdings Limited 

(Public, ASX:ACG)   Watch this stock   
Find more results for ACG

Key stats and ratios

Q2 (Jun '09) 2009
Net profit margin -31.78% -13.64%
Operating margin -32.29% -13.58%
EBITD margin - -12.15%
Return on average assets -45.57% -21.33%
Return on average equity -69.51% -31.88%
Employees 28 -

Address

Suite 11 West Ryde Corporate Centre 1059-1063 Victoria Road
West Ryde, NSW 2114
Australia
+61-2-98748761 (Phone)
+61-2-98749022 (Fax)

Website links

Atcor Medical Holdings Limited discussions

  View all discussions »

Description

AtCor Medical Holdings Limited is an Australia-based company. The Company is engaged in designing, manufacturing and marketing medical devices for use in cardiovascular management. The Company’s product range includes the SphygmoCor System. The SphygmoCor family of products provides tools for non-invasive assessment of the cardiovascular system and autonomic function. The SphygmoCor family includes SphygmoCor Px Aortic BP Waveform Analysis System, SphygmoCor Vx Pulse Wave Velocity System, SphygmoCor Mx Aortic BP Monitoring System and Heart Rate Variability System. The Company operates in three geographical areas: Americas; Europe, which includes Middle East and North Africa, and Asia Pacific, which includes Asia and Australia/New Zealand. The Company’s subsidiaries include AtCor Medical Pty Limited, AtCor Medical Inc. and AtCor Medical UK Limited.

Officers and directors

Duncan R. Ross
Chief Executive Officer, Managing Director, Executive Director
Age: 51
Peter Manley CPA
Chief Financial Officer, Company Secretary
Douglas Kurschinski
Senior Vice President - US Commercial Operations of AtCor Medical Inc.
Mark Harding
International Sales & Marketing Director of AtCor Medical Pty Ltd
Donal O'Dwyer
Independent Non-Executive Chairman of the Board
Age: 56
Michael O'Rourke M.D.
Non-Executive Director
Age: 72
Peter R. Jenkins
Non-Executive Independent Director
Age: 74
David L. Brookes
Non-Executive Independent Director
Age: 49